Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal -ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy

Al-Zubaydi Firas; Gao Dayuan; Kakkar Dipti; Li Shike; Adler Derek; Holloway Jennifer; Szekely Zoltan; Gu Zichao; Chan Nancy; Kumar Shicha; Love Susan; Sinko Patrick J.

首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal -ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy

【24h】

Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal -ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy

机译：用于治疗导管癌的乳腺导管内纳米型I：探索金属 - 激素络合以缓慢Ciclopirox释放，增强乳房持久性和功效

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Controlled Release: Official Journal of the Controlled Release Society 》 |2020年第1期| 共12页
作者
Al-Zubaydi Firas; Gao Dayuan; Kakkar Dipti; Li Shike; Adler Derek; Holloway Jennifer; Szekely Zoltan; Gu Zichao; Chan Nancy; Kumar Shicha; Love Susan; Sinko Patrick J.;
展开▼
作者单位

Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;

Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;

Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;

Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;

Rutgers Mol Imaging Ctr 41 Gordon Rd Suite D Piscataway NJ 08854 USA;

Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;

Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;

Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;

Rutgers Canc Inst New Jersey 195 Little Albany St New Brunswick NJ 08903 USA;

Rutgers Canc Inst New Jersey 195 Little Albany St New Brunswick NJ 08903 USA;

Dr Susan Love Res Fdn 16133 Ventura Suite 1000 Encino CA 91436 USA;

Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal -ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy [J] . Al-Zubaydi Firas, Gao Dayuan, Kakkar Dipti, Journal of Controlled Release: Official Journal of the Controlled Release Society . 2020 ,第1期

机译：用于治疗导管癌的乳腺导管内纳米型I：探索金属 - 激素络合以缓慢Ciclopirox释放，增强乳房持久性和功效
2. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: Ductal carcinoma in situ vs. invasive ductal carcinoma [J] . Nadrljanski Mirjan, Maksimovic Ruzica, Plesinac-Karapandzia Vesna, European Journal of Radiology . 2014 ,第8期

机译：动态对比增强磁共振成像在乳腺癌中的正增强积分值：原位导管癌与浸润性导管癌
3. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. [J] . Park K, Han S, Kim HJ, Histopathology: Official Journal of the British Division of the International Academy of Pathology . 2006 ,第6期

机译：通过荧光原位杂交和免疫组化测定纯导管癌原位以及浸润性导管癌的导管内和浸润成分中的HER2状态。
4. Diffusion-Weighted Imaging (DWI) for Breast Cancers Challenging to Diagnose Ductal Carcinoma in Situ (DCIS) and Invasive Lobular Carcinoma (ILC) [C] . Yoshifumi Kuroki, Katsuhiro Nasu, Seiko Kuroki, Digital mammography . 2010

机译：弥散加权成像（DWI）用于挑战性导管原位癌（DCIS）和侵袭性小叶癌（ILC）的乳腺癌
5. 14-3-3 zeta mediated epithelial -mesenchymal transition (EMT) contributes to ErbB2 overexpressing ductal carcinoma in situ (DCIS) progression into invasive breast cancer [D] . Lu, Jing 2008

机译：14-3-3 Zeta介导的上皮-间质转化（EMT）有助于ErbB2过表达导管原位癌（DCIS）演变为浸润性乳腺癌
6. Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma [O] . Jeeyeon Lee, Jin Hyang Jung, Wan Wook Kim, 2020

机译：乳腺癌患者乳腺癌手术决策的疗效：导管癌原位与侵入性导管癌
7. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma [O] . Takuya Moriya, Steven G. Silverberg 1994

机译：乳房的内部癌（导管癌原位）。纯非侵入性肿瘤与包括不同比例的浸润癌的比较
8. Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast [R] . SKinner, K. A. 2006

机译：评价DNa甲基化作为导管内治疗乳腺导管癌的靶点

Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal -ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy

著录项

相似文献

相关主题

期刊订阅